These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9816310)
1. Immunohistochemical detection of K-sam protein in stomach cancer. Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310 [TBL] [Abstract][Full Text] [Related]
2. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490 [TBL] [Abstract][Full Text] [Related]
3. A soluble form of K-sam/FGFR2 protein in the culture medium of human gastric cancer cells. Kishi T; Yoshida T; Terada M Biochem Biophys Res Commun; 1994 Aug; 202(3):1387-94. PubMed ID: 8060318 [TBL] [Abstract][Full Text] [Related]
4. Biological significance of gene amplification in carcinogenesis. Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251 [TBL] [Abstract][Full Text] [Related]
5. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Itoh H; Hattori Y; Sakamoto H; Ishii H; Kishi T; Sasaki H; Yoshida T; Koono M; Sugimura T; Terada M Cancer Res; 1994 Jun; 54(12):3237-41. PubMed ID: 8205545 [TBL] [Abstract][Full Text] [Related]
6. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658 [TBL] [Abstract][Full Text] [Related]
7. Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs. Ueda T; Sasaki H; Kuwahara Y; Nezu M; Shibuya T; Sakamoto H; Ishii H; Yanagihara K; Mafune K; Makuuchi M; Terada M Cancer Res; 1999 Dec; 59(24):6080-6. PubMed ID: 10626794 [TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene]. Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E Nihon Rinsho; 2001 Apr; 59 Suppl 4():53-9. PubMed ID: 11424439 [No Abstract] [Full Text] [Related]
9. Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence. Katoh O; Hattori Y; Sasaki H; Sakamoto H; Fujimoto K; Fujii T; Sugimura T; Terada M Cancer Res; 1993 Mar; 53(5):1136-41. PubMed ID: 8382556 [TBL] [Abstract][Full Text] [Related]
10. [New molecular prognostic markers in gastric carcinoma]. Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902 [TBL] [Abstract][Full Text] [Related]
11. Novel exons located more than 200 kb downstream of the previously described 3' exon of the K-sam gene for generating activated forms of KGF receptor. Ueda T; Sasaki H; Aoyagi K; Narikiyo M; Tsubosa Y; Kuwahara Y; Sakamoto H; Mafune K; Yoshida T; Makuuchi M; Terada M Biochem Biophys Res Commun; 1999 Nov; 265(3):739-45. PubMed ID: 10600490 [TBL] [Abstract][Full Text] [Related]
12. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116 [TBL] [Abstract][Full Text] [Related]
13. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors. Hattori Y; Odagiri H; Katoh O; Sakamoto H; Morita T; Shimotohno K; Tobinai K; Sugimura T; Terada M Cancer Res; 1992 Jun; 52(12):3367-71. PubMed ID: 1317750 [TBL] [Abstract][Full Text] [Related]
14. Amplified genes in cancer in upper digestive tract. Yoshida T; Sakamoto H; Terada M Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412 [TBL] [Abstract][Full Text] [Related]
15. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Ishii H; Yoshida T; Oh H; Yoshida S; Terada M Mol Cell Biol; 1995 Jul; 15(7):3664-71. PubMed ID: 7791773 [TBL] [Abstract][Full Text] [Related]
16. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Hughes SE Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516 [TBL] [Abstract][Full Text] [Related]
17. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation. Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932 [TBL] [Abstract][Full Text] [Related]
18. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Hattori Y; Odagiri H; Nakatani H; Miyagawa K; Naito K; Sakamoto H; Katoh O; Yoshida T; Sugimura T; Terada M Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5983-7. PubMed ID: 2377625 [TBL] [Abstract][Full Text] [Related]
19. K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase. Katoh M; Hattori Y; Sasaki H; Tanaka M; Sugano K; Yazaki Y; Sugimura T; Terada M Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2960-4. PubMed ID: 1313574 [TBL] [Abstract][Full Text] [Related]
20. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]